First Clinical Evaluation of an Allogeneic CD19- Directed CAR T-Cell Therapy in Progressive Multiple Sclerosis: Initial Results From the Phase 1 TG-Azercel-101 Study

Drug Category :
Conference Category :
Lead Author : Ontaneda D, et al.
Published Date : 23/10/2026
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2026/10/TG-Azer-cel-101-Study-MSToronto-Late-Breaking-Ontaneda-10.23.26.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top